Global Animal Intestinal Health Market Databank
The Animal Intestinal Health market was valued at $3,142.6 Million in 2020, and is projected to reach $5,303.3 Million by 2029 growing at a CAGR of 6.04% from 2021 to 2029. Probiotics segment is expected to be the highest contributor to this market, with $2,422.2 Million in 2020, and is anticipated to reach $4,042.8 Million by 2029, registering a CAGR of 5.91%. Immunostimulants segment is anticipated to reach $100.6 Million by 2029 with the highest CAGR of 10.10%. Probiotics and Phytogenics segments collectively expected to account for about 89.6% share of the Animal Intestinal Health market in 2020, with the former constituting around 77.1% share. Immunostimulants and Prebiotics segments are expected to witness significant growth rates at a CAGR of 10.10% and 6.88% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 10.4% in the overall Animal Intestinal Health market in 2020, and is anticipated to reach 11.6% by 2029.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook